Circulating biomarkers in familial cerebral cavernous malformationResearch in context

Autor: Francesca Lazzaroni, Jennifer M.T.A. Meessen, Ying Sun, Silvia Lanfranconi, Elisa Scola, Quintino Giorgio D'Alessandris, Laura Tassi, Maria Rita Carriero, Marco Castori, Silvia Marino, Adriana Blanda, Enrico B. Nicolis, Deborah Novelli, Roberta Calabrese, Nicolò M. Agnelli, Barbara Bottazzi, Roberto Leone, Selene Mazzola, Silvia Besana, Carlotta Catozzi, Luigi Nezi, Maria G. Lampugnani, Matteo Malinverno, Nastasja Grdseloff, Claudia J. Rödel, Behnam Rezai Jahromi, Niccolò Bolli, Francesco Passamonti, Peetra U. Magnusson, Salim Abdelilah-Seyfried, Elisabetta Dejana, Roberto Latini

Publikováno v: EBioMedicine, Vol 99, Iss , Pp 104914- (2024)

Summary: Background: Cerebral Cavernous Malformation (CCM) is a rare cerebrovascular disease, characterized by the presence of multiple vascular malformations that may result in intracerebral hemorrhages (ICHs), seizure(s), or focal neurological defi

Externí odkaz: https://doaj.org/article/5d07c7a73f1a46f0b5225cf9e0e0aa36

Cerebrovascular reactivity by quantitative magnetic resonance angiography with a co 2 challenge. Validation as a new imaging biomarker

Autor: Maria Grazia Bruzzone, Fabio Longaretti, F. Ghielmetti, Fady T. Charbel, Elisa Ciceri, Luigi Caputi, Gian Paolo Anzola, Maria Rita Carriero, Eugenio Parati, Giuseppe Faragò, Massimo Lamperti

Publikováno v: European Journal of Radiology. 83:1005-1010

Assessment of cerebrovascular reactivity (CVR) is essential in cerebrovascular diseases, as exhausted CVR may enhance the risk of cerebral ischemic events. Transcranial Doppler (TCD) with a vasodilatory stimulus is currently used for CVR evaluation.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37ffc9e21eb955fb30a0d817ac759966
https://doi.org/10.1016/j.ejrad.2014.03.001

ISNI 2012 Abstracts

Autor: Fabrizio Piazza, Margherita Gardinetti, Luisa Chiapparini, Jacopo C. DiFrancesco, Fabrizio Tagliavini, Maria Rita Carriero, Mario Savoiardo, M. Brioschi, Giuseppe Piscosquito, Irina Raicher, Giuseppe Billo, Francesca Lanzani, Antonio Colombo, Hideya Sakaguchi, Carlo Ferrarese, Giorgio Giaccone, Steven M. Greenberg

Publikováno v: Journal of Neuroimmunology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5e1e841d0035504550dc6da5f19a974
https://doi.org/10.1016/j.jneuroim.2012.10.001

Aspirin resistance determined with PFA-100 does not predict new thrombotic events in patients with stable ischemic cerebrovascular disease

Autor: Elena Corsini, Carla Brambilla, Giorgio B. Boncoraglio, Antonella Bodini, Maria Rita Carriero, Eugenio Parati

Publikováno v: Clinical neurology and neurosurgery (Dutch-Flem. ed.) 111 (2009): 270–273. doi:10.1016/j.clineuro.2008.11.001
info:cnr-pdr/source/autori:Boncoraglio G.; Bodini A.; Brambilla C.; Corsini E.; Carriero MR.; Parati E.A./titolo:Aspirin resistence determined with PFA-100 does not predict thrombotic events in patients with stable ischemic cerebrovascular disease/doi:10.1016%2Fj.clineuro.2008.11.001/rivista:Clinical neurology and neurosurgery (Dutch-Flem. ed.)/anno:2009/pagina_da:270/pagina_a:273/intervallo_pagine:270–273/volume:111

Objective Evidence is growing that some patients are not responsive to the antithrombotic action of aspirin. We prospectively evaluated the ability of aspirin resistance status, determined by PFA-100, to predict new thrombotic events in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68f34b5375053138cdcd956bb82dfed2
https://doi.org/10.1016/j.clineuro.2008.11.001

An Effect of the PAI-1 4G/5G Polymorphism on Cholesterol Levels May Explain Conflicting Associations with Myocardial Infarction and Stroke

Autor: Giorgio B. Boncoraglio, Emilio Ciusani, Carla Brambilla, Maria Rita Carriero, Eugenio Parati, Antonella Bodini

Publikováno v: Cerebrovascular diseases (Basel) 22 (2006): 191–195. doi:10.1159/000093604
info:cnr-pdr/source/autori:Boncoraglio G.B.; Bodini A.; Brambilla C.; Carriero M.R.; Ciusani E.; Parati E.A./titolo:An effect of PAI-1 4G%2F5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke/doi:10.1159%2F000093604/rivista:Cerebrovascular diseases (Basel)/anno:2006/pagina_da:191/pagina_a:195/intervallo_pagine:191–195/volume:22

Background and Purpose:The gene-encoding plasminogen activator inhibitor type 1 (PAI-1) has a common 4G/5G ‘functional’ polymorphism, and people homozygous for the 4G allele have higher PAI-1 plasma concentrations. The 4G/4G genotype is associate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034f91cb835ec8cf7741945c1397215d
https://doi.org/10.1159/000093604